PHARM — Pharming NV Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Pharming NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	205	192	207	213	168
Net Total Accounts Receivable
Net Total Receivables	31.9	27.6	25.3	42.6	50.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	263	249	278	316	278
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	21.7	33.2	39.1	33.5	24.1
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	418	397	426	463	400
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	76.8	46.8	59.7	78	73.8
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	235	204	221	244	179
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	183	193	205	219	221
Total Liabilities & Shareholders' Equity	418	397	426	463	400
Total Common Shares Outstanding